Concepedia

Author

Ke Geng

Rutgers, The State University of New JerseyORCID

Also Known As

Geng, Ke, Ke Geng

38

Publications

823

Citations

13

H-Index

15

Concepts

All Affiliations

Rutgers, The State University of New JerseyNew York UniversityRutgers New Jersey Medical SchoolOffice of ScienceNYU Langone Health
KG

About

Ke Geng is an author at Rutgers, The State University of New Jersey specializing in tumor biology, tumor immunology, and tumor immunity.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

45

2

Cell Biology

1

1

45

3

Immunology

1

1

45

4

Cell Signaling

1

1

45

5

Immune Surveillance

1

1

45

Ke Geng

×

14

Publications

736

Citations

13

H-Index

YearCitations

Pan-TAM Tyrosine Kinase Inhibitor BMS-777607 Enhances Anti–PD-1 mAb Efficacy in a Murine Model of Triple-Negative Breast Cancer

Canan Kasikara, Viralkumar Davra, David Calianese,

Cancer Research

2019

130

Phosphatidylserine Sensing by TAM Receptors Regulates AKT-Dependent Chemoresistance and PD-L1 Expression

Canan Kasikara, Sushil Kumar, Stanley Kimani,

Molecular Cancer Research

2017

122

Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity

Viralkumar Davra, Sushil Kumar, Ke Geng,

Cancer Research

2020

90

KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition

Yuanwang Pan, Han Han, Hai Hu,

Cancer Cell

2022

81

Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6

Ke Geng, Sushil Kumar, Stanley Kimani,

Frontiers in Immunology

2017

77

Crk adaptor protein promotes PD-L1 expression, EMT and immune evasion in a murine model of triple-negative breast cancer

Sushil Kumar, Viralkumar Davra, Alison E. Obr,

OncoImmunology

2017

45

Loss of <i>TSC1/TSC2</i> sensitizes immune checkpoint blockade in non–small cell lung cancer

Qingyuan Huang, Fei Li, Hai Hu,

Science Advances

2022

37

Efficacy of Targeting SARS-CoV-2 by CAR-NK Cells

Minh Ma, Saiaditya Badeti, Ke Geng,

2020

36

Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms

Chuan Xu, Annie Wang, Ke Geng,

Viruses

2021

30

Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase

Stanley Kimani, Sushil Kumar, Viralkumar Davra,

Cell Communication and Signaling

2016

29

Page 1